drugset
drugset / Trial / NCT03891264

Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain

NCT03891264 ↗

Phase 4 Terminated 7 enrolled Massachusetts General Hospital
NaSingle-groupOpen-labelBasic science

Summary

In this research, the study team will use brain imaging to evaluate the presence of neuroinflammation in the brains and spinal cords of patients with low back pain, and whether CBD effects levels of neuroinflammation. The efficacy of CBD use for low back pain treatment will also be evaluated by observing whether CBD administration will reduce neuroinflammation and low back pain symptoms.

Timeline

Start
2019-11-13
Primary completion
2020-11-23
Completion
2020-11-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 10 mg/kg Oral

Indications

No indication recorded.